UBS Group’s Transcat TRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25M Sell
30,691
-5,617
-15% -$395K ﹤0.01% 4866
2025
Q4
$2.06M Sell
36,308
-8,480
-19% -$529K ﹤0.01% 4954
2025
Q3
$3.28M Buy
44,788
+2,036
+5% +$164K ﹤0.01% 4471
2025
Q2
$3.67M Sell
42,752
-12,877
-23% -$1.05M ﹤0.01% 4192
2025
Q1
$4.14M Sell
55,629
-1,229
-2% -$103K ﹤0.01% 3982
2024
Q4
$6.01M Buy
56,858
+21,868
+62% +$2.43M ﹤0.01% 3616
2024
Q3
$4.23M Buy
34,990
+6,199
+22% +$770K ﹤0.01% 3246
2024
Q2
$3.45M Sell
28,791
-5,995
-17% -$708K ﹤0.01% 3213
2024
Q1
$3.88M Sell
34,786
-300
-0.9% -$31.8K ﹤0.01% 3245
2023
Q4
$3.84M Buy
35,086
+1,171
+3% +$113K ﹤0.01% 3064
2023
Q3
$3.32M Sell
33,915
-2,003
-6% -$191K ﹤0.01% 2961
2023
Q2
$3.06M Sell
35,918
-1,755
-5% -$150K ﹤0.01% 3084
2023
Q1
$3.37M Sell
37,673
-271
-0.7% -$23.1K ﹤0.01% 2891
2022
Q4
$2.69M Buy
37,944
+330
+0.9% +$25.1K ﹤0.01% 3086
2022
Q3
$2.85M Sell
37,614
-422
-1% -$29.2K ﹤0.01% 2837
2022
Q2
$2.16M Buy
38,036
+1,274
+3% +$88.1K ﹤0.01% 3090
2022
Q1
$2.98M Sell
36,762
-4,470
-11% -$363K ﹤0.01% 3056
2021
Q4
$3.81M Buy
41,232
+1,473
+4% +$124K ﹤0.01% 3132
2021
Q3
$2.56M Buy
39,759
+946
+2% +$60.4K ﹤0.01% 3365
2021
Q2
$2.19M Sell
38,813
-4,251
-10% -$221K ﹤0.01% 3493
2021
Q1
$2.11M Sell
43,064
-9,716
-18% -$417K ﹤0.01% 3511
2020
Q4
$1.83M Sell
52,780
-5,963
-10% -$187K ﹤0.01% 3477
2020
Q3
$1.72M Sell
58,743
-12,483
-18% -$355K ﹤0.01% 3189
2020
Q2
$1.84M Buy
71,226
+5,127
+8% +$133K ﹤0.01% 2953
2020
Q1
$1.75M Buy
66,099
+18,175
+38% +$545K ﹤0.01% 2876
2019
Q4
$1.53M Buy
47,924
+1,689
+4% +$51.4K ﹤0.01% 3815
2019
Q3
$1.18M Buy
46,235
+3,342
+8% +$78.9K ﹤0.01% 3814
2019
Q2
$1.1M Sell
42,893
-1,709
-4% -$41.9K ﹤0.01% 3685
2019
Q1
$1.02M Sell
44,602
-27,951
-39% -$630K ﹤0.01% 3565
2018
Q4
$1.38M Buy
72,553
+2,974
+4% +$61.4K ﹤0.01% 3393
2018
Q3
$1.59M Sell
69,579
-1,970
-3% -$44.8K ﹤0.01% 3424
2018
Q2
$1.35M Buy
71,549
+5,084
+8% +$90.1K ﹤0.01% 3516
2018
Q1
$1.04M Buy
66,465
+25,664
+63% +$384K ﹤0.01% 3673
2017
Q4
$581K Buy
40,801
+603
+2% +$8.1K ﹤0.01% 4190
2017
Q3
$545K Buy
40,198
+3,396
+9% +$44.1K ﹤0.01% 4147
2017
Q2
$447K Buy
36,802
+4,400
+14% +$53K ﹤0.01% 4192
2017
Q1
$412K Sell
32,402
-226
-0.7% -$2.63K ﹤0.01% 4182
2016
Q4
$352K Buy
32,628
+1,851
+6% +$19.4K ﹤0.01% 4371
2016
Q3
$336K Buy
30,777
+337
+1% +$3.5K ﹤0.01% 4186
2016
Q2
$306K Sell
30,440
-546
-2% -$5.67K ﹤0.01% 4245
2016
Q1
$314K Sell
30,986
-1,070
-3% -$10.3K ﹤0.01% 4154
2015
Q4
$319K Buy
32,056
+2,884
+10% +$27.5K ﹤0.01% 4306
2015
Q3
$285K Buy
29,172
+4,676
+19% +$44.4K ﹤0.01% 4358
2015
Q2
$231K Buy
24,496
+4,060
+20% +$40.3K ﹤0.01% 4750
2015
Q1
$199K Buy
20,436
+14,162
+226% +$135K ﹤0.01% 4880
2014
Q4
$64K Buy
+6,274
New +$61.5K ﹤0.01% 6184

Other funds holding TRNS

UBS Group's TRNS Position: Q1 2026 in Review

UBS Group reduced its Transcat (TRNS) stake by 15% in Q1 2026, selling an estimated $395K and leaving 30,691 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #4866.

UBS Group first reported a position in TRNS in Q4 2014 and has held it in 46 quarters since. The position peaked at $6.01M in Q4 2024. 159 funds tracked by Wall St. Rank hold TRNS as of Q1 2026.

  • UBS Group held 30,691 shares of Transcat worth $2.25M as of Q1 2026.
  • UBS Group sold 5,617 Transcat shares in Q1 2026, an estimated $395K.
  • Transcat made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4866 holding.
  • UBS Group first reported a position in Transcat in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Transcat position peaked at $6.01M in Q4 2024.
  • 159 funds tracked by Wall St. Rank held Transcat as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.